TCL Archive As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move September 13, 2002
TCL Archive “Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.” July 7, 1995
TCL Archive AMC Cancer Center, Rose Cancer Program Name Douglass Tormey Director; ECG Plans Move To Denver September 4, 1992
TCL Archive Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure August 12, 1988
